BAP1tism of a tumor suppressor

Clin Cancer Res. 2012 Jan 15;18(2):323-5. doi: 10.1158/1078-0432.CCR-11-2870. Epub 2011 Dec 2.

Abstract

Driving cancer cells into a more differentiated state is a rational therapeutic approach. Primary uveal melanoma cells with a propensity to metastasize have less-differentiated features than their less aggressive counterparts. Treatment of uveal melanoma cells with histone deacetylase inhibitors induces a more differentiated phenotype with resultant lower growth capacity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Cell Differentiation / drug effects*
  • Histone Deacetylase Inhibitors / therapeutic use*
  • Humans
  • Melanoma / drug therapy*
  • Uveal Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Histone Deacetylase Inhibitors

Supplementary concepts

  • Uveal melanoma